Australian-wide survey on Drug-Drug Interaction alerts

15-May-2020


The University of Sydney Faculty of Medicine and Health is running a research study about drug-drug interaction alerts – with the aim of examining prescriber perceptions of drug-drug interaction alerts in their electronic medication management systems.

All Australian doctors who see drug-drug interaction alerts while prescribing are eligible to take part in the study and the lead researcher, Associate Professor Melissa Baysari has asked that we promote this study among members.

This study will involve completing an online survey about the drug-drug interaction alerts you see in your electronic medication management system. The survey will take approximately 5 minutes to complete.

Follow this link to complete the survey https://bit.ly/2WofQJe

Background

Although drug-drug interaction (DDI) alerts have the potential to warn prescribers of errors in their medication orders, studies have shown that too many irrelevant DDI alerts are often presented, leading to user annoyance and frustration, and to alerts being ignored by users. Our own research has shown that hospital prescribers in Australia are presented with very large numbers of computerised alerts. Although some small-scale studies have explored prescriber perspectives of DDI alerts, no large-scale multi-site studies have been undertaken. This study aims to examine prescribers’ perceptions and experiences of drug-drug interaction alerts in electronic medication management systems in use in Australia. Findings will be used to advocate for the inclusion of only well-designed, targeted DDI alerts in electronic systems.